DAVID SAVOIE: Open Payments
NPI 1356098842 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,738 in 99 payments from 16 companies in 2025. Trend: 2023 $13 · 2024 $344 · 2025 $2,738
Food & beverage: $2,738
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 18 | $446 |
| Alkermes, Inc. | 16 | $402 |
| Otsuka America Pharmaceutical, Inc. | 14 | $393 |
| Axsome Therapeutics, Inc. | 11 | $295 |
| ABBVIE INC. | 13 | $276 |
| Indivior Inc. | 8 | $238 |
| E.R. Squibb & Sons, L.L.C. | 2 | $147 |
| Vanda Pharmaceuticals Inc. | 4 | $124 |
| Theratechnologies Inc. | 3 | $120 |
| Gilead Sciences, Inc. | 1 | $112 |
Products named: BRIXADI, Auvelity, VRAYLAR, SUBLOCADE, ABILIFY MAINTENA, VIVITROL, COBENFY, LYBALVI.
Industry payments across LA — which companies pay providers there.
